Erratum: Double-blinded is not better than “mutually enlightened”: implications of Lord-Bessen et al. (JNCI Cancer Spectrum (2023) 7: 2 (pkad013) DOI: 10.1093/jncics/pkad013)

Carolyn Schwartz, Bruce D. Rapkin

Research output: Contribution to journalComment/debatepeer-review

Abstract

This is a correction to: Carolyn E Schwartz, ScD, Bruce D Rapkin, PhD, Double-blinded is not better than “mutually enlightened”: implications of Lord-Besson et al., JNCI Cancer Spectrum, Volume 7, Issue 2, April 2023, pkad013, https://doi.org/10.1093/jncics/pkad013 In the originally published version of this manuscript, Jennifer Lord-Bessen’s name was incorrectly spelt, in the title and reference list, as Lord-Besson. This error has been corrected online.

Original languageEnglish (US)
Article numberpkad037
JournalJNCI Cancer Spectrum
Volume7
Issue number3
DOIs
StatePublished - Jun 1 2023

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Erratum: Double-blinded is not better than “mutually enlightened”: implications of Lord-Bessen et al. (JNCI Cancer Spectrum (2023) 7: 2 (pkad013) DOI: 10.1093/jncics/pkad013)'. Together they form a unique fingerprint.

Cite this